D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
First Bancorp
FBP
$4.44B
| $13.6M | 0.01% |
1,207,818
-528,167
| -30% | -$5.55M |
|
1077
Rocket Pharmaceuticals
RCKT
$359M
| $13.6M | 0.01% |
306,250
-12,388
| -4% | -$680K |
|
1078
CRH
CRH
$67.9B
| $13.6M | 0.01% |
+288,741
| New | +$13M |
|
1079
PUT
Newmont
NEM
$98.6B
| $13.6M | 0.01% |
225,000
+103,200
| +85% | +$6.17M |
|
|
SRNGU
1080
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
| $13.5M | 0.01% |
+1,338,872
| New | +$13.9M |
|
1081
CALL
Nike
NKE
$61.9B
| $13.5M | 0.01% |
101,900
-204,900
| -67% | -$28.5M |
|
|
STMP
1082
PUT
DELISTED
Stamps.com, Inc.
STMP
| $13.5M | 0.01% |
67,500
+10,000
| +17% | +$2.13M |
|
|
Y
1083
CALL
DELISTED
Alleghany Corp
Y
| $13.5M | 0.01% |
21,500
+1,500
| +8% | +$928K |
|
1084
PUT
Workday
WDAY
$35.8B
| $13.4M | 0.01% |
54,100
-65,100
| -55% | -$16.1M |
|
1085
Silicon Motion
SIMO
$8.58B
| $13.4M | 0.01% |
226,088
-26,730
| -11% | -$1.52M |
|
1086
W.W. Grainger
GWW
$65.6B
| $13.4M | 0.01% |
33,423
-57,044
| -63% | -$22.1M |
|
|
ADN
1087
DELISTED
Advent Technologies
ADN
| $13.4M | 0.01% |
+33,333
| New | +$15.1M |
|
1088
Gaotu Techedu
GOTU
$377M
| $13.4M | 0.01% |
395,179
+384,615
| +3,641% | +$31.3M |
|
1089
Pediatrix Medical
MD
$2.15B
| $13.4M | 0.01% |
525,283
-380,400
| -42% | -$9.74M |
|
1090
Tenaris
TS
$28.8B
| $13.3M | 0.01% |
586,036
-329,506
| -36% | -$6.3M |
|
|
GTS
1091
DELISTED
Triple-S Management Corporation
GTS
| $13.2M | 0.01% |
508,169
-18,518
| -4% | -$457K |
|
1092
PUT
Markel Group
MKL
$25.1B
| $13.2M | 0.01% |
11,600
-10,000
| -46% | -$10.8M |
|
|
BSN
1093
DELISTED
Broadstone Acquisition Corp.
BSN
| $13.2M | 0.01% |
+1,350,000
| New | +$13.6M |
|
1094
Gaming and Leisure Properties
GLPI
$12.7B
| $13.2M | 0.01% |
310,715
| – | – |
|
1095
CALL
Blackrock
BLK
$164B
| $13.1M | 0.01% |
17,400
-27,000
| -61% | -$19.6M |
|
1096
CALL
Equinix
EQIX
$105B
| $13.1M | 0.01% |
+19,300
| New | +$13.2M |
|
|
TVTY
1097
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $13M | 0.01% |
584,612
+237,650
| +68% | +$5.45M |
|
1098
PUT
Lemonade
LMND
$4.78B
| $13M | 0.01% |
+140,000
| New | +$18.1M |
|
1099
Celanese
CE
$4.91B
| $12.9M | 0.01% |
86,261
+60,236
| +231% | +$8.27M |
|
1100
Haemonetics
HAE
$3.65B
| $12.9M | 0.01% |
116,386
+79,166
| +213% | +$9.8M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.